Related Experiment Video

Updated: Mar 7, 2026

A Treatment Package without Escape Extinction to Address Food Selectivity
04:23

A Treatment Package without Escape Extinction to Address Food Selectivity

Published on: August 21, 2015

12.2K

Adapting the low FODMAP diet to special populations: infants and children

Marina Iacovou1

  • 1Department of Gastroenterology, Central Clinical School, The Alfred Centre, Monash University, Melbourne, Victoria, Australia.

Journal of Gastroenterology and Hepatology
|March 1, 2017
PubMed

Insights

This review explores dietary therapies for infantile colic and examines evidence for children with irritable bowel syndrome (IBS). It highlights the complex factors influencing pediatric gut health management.

Area of Science:

  • Pediatric Gastroenterology
  • Nutritional Science
  • Child Psychology

Background:

  • Gut-related symptoms in children present complex management challenges.
  • Pediatric gut health is influenced by psychological, behavioral, social, and family factors.
  • Infantile colic and pediatric irritable bowel syndrome (IBS) are common gastrointestinal conditions.

Purpose of the Study:

  • To review potential dietary therapies for infantile colic.
  • To evaluate the evidence and dietary considerations for pediatric IBS.
  • To provide insights into managing gut-related symptoms in children.

Main Methods:

  • Literature review of studies on dietary interventions for infantile colic.
  • Systematic review of evidence for dietary management in pediatric IBS.
  • Analysis of factors influencing pediatric gut health.

Main Results:

  • Evidence for specific dietary therapies in infantile colic is emerging.
  • Dietary modifications show promise in managing symptoms of pediatric IBS.
  • A multifactorial approach is crucial for effective management.

Conclusions:

  • Dietary interventions are a key consideration for infantile colic and pediatric IBS.
  • Further research is needed to establish optimal dietary guidelines.
  • Integrated management strategies are essential for pediatric gut health.

Keywords:
FODMAPsIBSchildrencolicfunctional gastrointestinal disordersinfants

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.5K
Recapitulating Suckling-to-Weaning Transition In Vitro using Fetal Intestinal Organoids08:15

Recapitulating Suckling-to-Weaning Transition In Vitro using Fetal Intestinal Organoids

Published on: November 15, 2019

6.5K

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
987
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
575
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
615
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
342
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405